Drug Profile
ONO 4127
Alternative Names: ONO 4127NaLatest Information Update: 26 May 2006
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class
- Mechanism of Action Prostaglandin D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis
Most Recent Events
- 30 Apr 2006 Discontinued - Phase-I for Allergic rhinitis in United Kingdom (PO)
- 18 May 2005 Ono Pharmaceutical has completed a Phase-I trial in Allergic rhinitis in the UK
- 30 May 2003 Phase-I clinical trials in Allergic rhinitis in United Kingdom (PO)